• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑出血后的神经外科治疗结果:Factor Seven for Acute Hemorrhagic Stroke Trial(FAST)的研究结果。

Neurosurgical outcomes after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST).

机构信息

Department of Neurology, University of Heidelberg, Heidelberg, Germany.

出版信息

J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4):287-94. doi: 10.1016/j.jstrokecerebrovasdis.2009.12.008. Epub 2010 May 8.

DOI:10.1016/j.jstrokecerebrovasdis.2009.12.008
PMID:20452785
Abstract

The value of neurosurgical interventions after spontaneous intracerebral hemorrhage (SICH) is uncertain. We evaluated clinical outcomes in patients diagnosed with SICH within 3 hours of symptom onset who underwent hematoma evacuation or external ventricular drainage (EVD) of the hematoma in the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST). FAST was a randomized, multicenter, double-blind, placebo-controlled trial conducted between May 2005 and February 2007 at 122 sites in 22 countries. Neurosurgical procedures (hematoma evacuation and external ventricular drainage) performed at any point after hospital admission were prospectively recorded. Clinical outcomes evaluated were post-SICH disability, as assessed by the modified Rankin Scale; neurologic impairment, as assessed by the National Institutes of Health Stroke Scale; and mortality at 90 days after SICH onset. The impact of neurosurgical procedures on clinical outcomes was evaluated using multivariate logistic regression analysis, controlling for relevant baseline characteristics. Fifty-five of 821 patients underwent neurosurgery. Patients who underwent hematoma evacuation or EVD were on average younger, had greater baseline neurologic impairment, and lower levels of consciousness compared with patients who did not undergo neurosurgery. After adjusting for these differences and other relevant baseline characteristics, we found that neurosurgery was generally associated with unfavorable outcomes at day 90. Among the patients who underwent hematoma evacuation, those with lobar ICH had less ICH expansion than those with deep gray matter ICH, and the smaller expansion was associated with lower mortality. ICH volume was substantially decreased in patients who underwent hematoma evacuation between 24 and 72 hours after hospital admission, and this was associated with better clinical outcome. In conclusion, a small number of patients who underwent neurosurgery in FAST exhibited no overall clinical benefit from neurosurgical intervention, although outcomes varied by type of surgery, time of surgery, and hematoma location. Our findings support the need for further research into the value of neurosurgery in patients with SICH.

摘要

自发性脑出血(ICH)后神经外科干预的价值尚不确定。我们评估了在症状发作后 3 小时内接受血肿清除术或血肿外引流术(EVD)的 FAST 试验(Factor Seven for Acute Hemorrhagic Stroke Trial)中诊断为 ICH 的患者的临床结局。FAST 是一项在 2005 年 5 月至 2007 年 2 月期间在 22 个国家的 122 个地点进行的随机、多中心、双盲、安慰剂对照试验。入院后任何时间进行的神经外科手术(血肿清除术和外引流术)均前瞻性记录。评估的临床结局是 ICH 后残疾,采用改良 Rankin 量表评估;神经功能损伤,采用 NIH 卒中量表评估;ICH 发病后 90 天的死亡率。采用多变量逻辑回归分析评估神经外科手术对临床结局的影响,控制相关基线特征。821 例患者中有 55 例接受了神经外科手术。与未接受神经外科手术的患者相比,接受血肿清除术或 EVD 的患者平均年龄较小,基线神经功能损伤更严重,意识水平更低。在调整这些差异和其他相关基线特征后,我们发现神经外科手术通常与 90 天的不良结局相关。在接受血肿清除术的患者中,脑叶 ICH 患者的 ICH 扩展量小于深部灰质 ICH 患者,而较小的扩展与较低的死亡率相关。在入院后 24 至 72 小时内接受血肿清除术的患者中,ICH 体积显著减少,并且与更好的临床结局相关。总之,在 FAST 中接受神经外科手术的少数患者并未从神经外科干预中获得总体临床获益,尽管手术类型、手术时间和血肿部位不同,结果也有所不同。我们的研究结果支持进一步研究神经外科手术在自发性脑出血患者中的价值。

相似文献

1
Neurosurgical outcomes after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST).脑出血后的神经外科治疗结果:Factor Seven for Acute Hemorrhagic Stroke Trial(FAST)的研究结果。
J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4):287-94. doi: 10.1016/j.jstrokecerebrovasdis.2009.12.008. Epub 2010 May 8.
2
Recombinant factor VIIa plus surgery for intracerebral hemorrhage.重组凝血因子VIIa联合手术治疗脑出血
Can J Neurol Sci. 2008 Nov;35(5):567-72. doi: 10.1017/s0317167100009343.
3
Rates and outcomes of neurosurgical treatment for postthrombolytic intracerebral hemorrhage in patients with acute ischemic stroke.溶栓后急性缺血性脑卒中患者的神经外科治疗的发生率和结果。
World Neurosurg. 2014 Nov;82(5):678-83. doi: 10.1016/j.wneu.2013.07.079. Epub 2013 Aug 1.
4
The Effect of Tranexamic Acid on Neurosurgical Intervention in Spontaneous Intracerebral Hematoma: Data From 121 Surgically Treated Participants From the Tranexamic Acid in IntraCerebral Hemorrhage-2 Randomized Controlled Trial.氨甲环酸对自发性脑出血神经外科干预的影响:来自氨甲环酸脑出血-2 随机对照试验 121 例手术治疗参与者的数据。
Neurosurgery. 2024 Sep 1;95(3):605-616. doi: 10.1227/neu.0000000000002961. Epub 2024 May 24.
5
Prognostic Significance of Ultraearly Hematoma Growth in Spontaneous Intracerebral Hemorrhage Patients Receiving Hematoma Evacuation.接受血肿清除术的自发性脑出血患者超早期血肿扩大的预后意义
World Neurosurg. 2018 Jan;109:e651-e654. doi: 10.1016/j.wneu.2017.10.049. Epub 2017 Oct 17.
6
Global differences in patient characteristics, case management and outcomes in intracerebral hemorrhage: the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.脑出血患者特征、病例管理及预后的全球差异:急性出血性卒中的凝血因子 VII(FAST)试验
Cerebrovasc Dis. 2009;28(1):55-64. doi: 10.1159/000219298. Epub 2009 May 20.
7
Recombinant activated factor VII for acute intracerebral hemorrhage.重组活化凝血因子 VII 用于急性脑出血
N Engl J Med. 2005 Feb 24;352(8):777-85. doi: 10.1056/NEJMoa042991.
8
The Effect of External Ventricular Drain Use in Intracerebral Hemorrhage.脑室外引流在脑出血中的应用效果
World Neurosurg. 2016 Oct;94:309-318. doi: 10.1016/j.wneu.2016.07.022. Epub 2016 Jul 17.
9
Quality of life after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.脑出血后的生活质量:急性出血性卒中的凝血因子 VII(FAST)试验结果
Stroke. 2009 May;40(5):1677-82. doi: 10.1161/STROKEAHA.108.538967. Epub 2009 Mar 5.
10
Depressed mood after intracerebral hemorrhage: the FAST trial.脑出血后情绪低落:FAST试验
Cerebrovasc Dis. 2009;27(4):353-60. doi: 10.1159/000202012. Epub 2009 Feb 14.

引用本文的文献

1
Early Minimally Invasive Removal of Intracerebral Hemorrhage (ENRICH): Study protocol for a multi-centered two-arm randomized adaptive trial.早期微创清除脑内血肿(ENRICH):一项多中心双臂随机适应性试验的研究方案
Front Neurol. 2023 Mar 16;14:1126958. doi: 10.3389/fneur.2023.1126958. eCollection 2023.
2
External ventricular drain placement is associated with lower mortality after intracerebral hemorrhage with intraventricular hemorrhage.对于伴有脑室出血的脑出血患者,放置脑室外引流与较低的死亡率相关。
Int J Emerg Med. 2022 Sep 15;15(1):51. doi: 10.1186/s12245-022-00450-4.
3
Atorvastatin combined with low-dose dexamethasone improves the neuroinflammation and survival in mice with intracerebral hemorrhage.
阿托伐他汀联合小剂量地塞米松可改善脑出血小鼠的神经炎症并提高其生存率。
Front Neurosci. 2022 Aug 22;16:967297. doi: 10.3389/fnins.2022.967297. eCollection 2022.
4
Dose-dependent benefits of iron-magnetic nanoparticle-coated human umbilical-derived mesenchymal stem cell treatment in rat intracranial hemorrhage model.铁磁纳米颗粒包被的人脐带间充质干细胞治疗对大鼠颅内出血模型的剂量依赖性获益。
Stem Cell Res Ther. 2022 Jun 21;13(1):265. doi: 10.1186/s13287-022-02939-4.
5
Clinical Evaluation of Herbal Medicine (ICH-012) in Treating Acute Cerebral Haemorrhage: Safety and Efficacy from 6- to 72-Hour Time Window (CRRICHTrial-II).中药治疗急性脑出血的临床评价(ICH - 012):6至72小时时间窗内的安全性与有效性(CRRICHTrial - II)
Evid Based Complement Alternat Med. 2018 Aug 26;2018:3120179. doi: 10.1155/2018/3120179. eCollection 2018.
6
Treatment of 817 patients with spontaneous supratentorial intracerebral hemorrhage: characteristics, predictive factors and outcome.817例自发性幕上脑出血患者的治疗:特征、预测因素及预后
Clin Pract. 2012 May 17;2(3):e56. doi: 10.4081/cp.2012.e56. eCollection 2012 May 29.
7
Surgical trials in intracerebral hemorrhage.脑出血的外科试验。
Stroke. 2013 Jun;44(6 Suppl 1):S79-82. doi: 10.1161/STROKEAHA.113.001494.
8
Hemorrhagic stroke: introduction.出血性中风:引言。
Stroke. 2013 Jun;44(6 Suppl 1):S65-6. doi: 10.1161/STROKEAHA.113.000856.